Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Novartis AG (NYSE:NVS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Options
Recent Events
Aug 16Earnings Announcement
Location
Lichtstrasse 35, CH-4002 Basel
Switzerland, Switzerland
Phone: (908) 522-6899
Fax: (908) 522-6897
Email: joseph.schepers@group.novartis.com
Employees (last reported count): 70,166
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Websites
 ·Home Page
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 11%
·Institutional: 3% (3% of float)
(262 institutions)
·Net Inst. Buying: 14.3M shares (+15.72%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Novartis AG is engaged in sales and in innovation in its core businesses: pharmaceuticals, generics, consumer health, eyecare products and medicines, and animal health. The Company currently operates in five principal industry sectors: Pharmaceuticals, Generics, Consumer Health, CIBA Vision and Animal Health. Novartis Pharmaceuticals discovers, develops, manufactures and markets prescription medicines. Novartis Generics provides off-patent pharmaceutical products and substances. Novartis Consumer Health develops, manufactures and markets a wide range of health and medical nutrition products and a portfolio of over-the-counter self-medication brands. CIBA Vision is engaged in the research, development and manufacturing of eye care products, namely soft contact lenses, lens care products, ophthalmic pharmaceuticals and ophthalmic surgical products. Novartis Animal Health maintains and improves the health and well being of companion animals and farm animals.
More from Market Guide: Expanded Business Description

Financial Summary
NVS is engaged in sales and product innovation in the areas of pharmaceuticals, generics, consumer health, eye care and animal health. For the six months ended 6/01, revenues rose 11% to CHF15.46 billion. Earnings from continuing operations according to US GAAP fell 22% to CHF2.58 billion. Revenues reflect strength in pharmaceuticals, including Voltaren and Lamisil, generics and consumer health. Earnings refelct higher marketing costs and a CHF700M in-process US GAAP charge.
More from Market Guide: Significant Developments

Officers

Position
Daniel Vasella, 46Chairman, CEO
Hans-Jorg Rudloff, 59Vice Chairman
Helmut Sihler, 45Vice Chairman
Raymond Breu, 54CFO
Ingrid Duplain, 55Sec., Director
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:NVSAs of 31-Aug-2001
Price and Volume
52-Week Low
on 11-July-2001
$32.70 
Recent Price$36.47 
52-Week High
on 3-Jan-2001
$46.875
Beta0.48 
Daily Volume (3-month avg)620.6K
Daily Volume (10-day avg)406.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-5.0%
52-Week Change
relative to S&P500
+27.5%
Share-Related Items
Market Capitalization$95.1B
Shares Outstanding2.61B
Float2.32B
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 11-May-2000
Per-Share Data
Book Value (mrq)$8.54 
Earnings (ttm)$1.27 
Earnings (mrq)$0.62 
Sales (ttm)$7.57 
Cash (mrq)$3.49 
Valuation Ratios
Price/Book (mrq)4.27 
Price/Earnings (ttm)28.76 
Price/Sales (ttm)4.82 
Income Statements
Sales (ttm)$19.4B
EBITDA (ttm)$5.13B
Income available to common (ttm)$3.25B
Profitability
Profit Margin (ttm)21.0%
Operating Margin (ttm)21.3%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)11.10%
Return on Equity (ttm)14.57%
Financial Strength
Current Ratio (mrq)1.92 
Debt/Equity (mrq)0.21 
Total Cash (mrq)$9.05B
Short Interest
As of 8-Aug-2001
Shares Short2.13M
Percent of Float0.1%
Shares Short
(Prior Month)
1.22M
Short Ratio5.17 
Daily Volume411.0K
ADR Information
Shares/ADR1
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001);   dollar amounts based on an exchange rate of 1.67 Swiss Francs/Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.